Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

    Children with diffuse intrinsic pontine glioma (DIPG) need new and more efficient treatments. They can be developed at relapse or at diagnosis, but therefore they must be combined with radiotherapy. Survival o...

    M. J. Lobon-Iglesias, G. Giraud, D. Castel, C. Philippe in Journal of Neuro-Oncology (2018)

  2. Article

    CAR-T cells: the narrow path between hope and bankruptcy?

    C Chabannon, J Kuball, E Mcgrath, P Bader, C Dufour in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    A French retrospective study on clinical outcome in 102 choroid plexus tumors in children

    The aim of this study was to review and describe therapeutic approaches in children with choroid plexus tumor (CPT) based on a nationwide series. The World Health Organization classification subdivides these r...

    A. Siegfried, S. Morin, C. Munzer, M. B. Delisle, M. Gambart in Journal of Neuro-Oncology (2017)

  4. Article

    Open Access

    Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

    Hematopoietic stem cell transplantation (HSCT) is an established procedure for many acquired and congenital disorders of the hematopoietic system. A record number of 42 171 HSCT in 37 626 patients (16 030 allo...

    J R Passweg, H Baldomero, P Bader, C Bonini, R F Duarte in Bone Marrow Transplantation (2017)

  5. No Access

    Article

    Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

    Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 000 transplants reported in 2014. Transplant-related mortality remains high in allogeneic HSCT (10–20%); high-...

    J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro in Bone Marrow Transplantation (2017)

  6. No Access

    Article

    Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration

    M E Dourthe, N Ternès, D Gajda, A Paci, C Dufour, E Benhamou in Bone Marrow Transplantation (2016)

  7. No Access

    Article

    Busulfan–melphalan in high-risk neuroblastoma: the 30-year experience of a single institution

    High-dose chemotherapy (HDC) was investigated in high-risk neuroblastoma (HR-NBL) to reduce the risk of relapse. We report the results of the 30-year experience of a cohort of patients with HR-NBL treated with...

    S Proust-Houdemont, C Pasqualini, P Blanchard, C Dufour in Bone Marrow Transplantation (2016)

  8. Article

    Open Access

    Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. T...

    J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro in Bone Marrow Transplantation (2016)

  9. No Access

    Article

    Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation

    S Pagliuca, L Gérard, A Kulasekararaj, M Eapen, D Boutboul in Bone Marrow Transplantation (2016)

  10. No Access

    Article

    Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients

    High-risk neuroblastoma is characterised by poor long-term survival, especially for very high-risk (VHR) patients (poor response of metastases after induction therapy). We report the results of an intensified ...

    C Pasqualini, C Dufour, G Goma, M-A Raquin, V Lapierre in Bone Marrow Transplantation (2016)

  11. No Access

    Article

    Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature

    Atypical teratoid rhabdoid tumour (ATRT) is a malignant tumour of the central nervous system with a dismal prognosis. There is no consensus on optimal treatment and different multimodal strategies are currentl...

    D. Schrey, F. Carceller Lechón, G. Malietzis, L. Moreno in Journal of Neuro-Oncology (2016)

  12. No Access

    Article

    Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

    Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-rel...

    R Peffault de Latour, C Peters, B Gibson, B Strahm in Bone Marrow Transplantation (2015)

  13. No Access

    Article

    Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults

    The prognosis of primary disseminated multifocal metastatic Ewing’s sarcoma (PDMES) is poor even if a slight improvement has been achieved with high-dose alkylating agent-containing chemotherapy. To enhance tr...

    S Loschi, C Dufour, O Oberlin, G Goma, D Valteau-Couanet in Bone Marrow Transplantation (2015)

  14. No Access

    Article

    Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

    This is the sixth special report that the European Society for Blood and Marrow Transplantation regularly publishes on the current practice and indications for haematopoietic SCT for haematological diseases, s...

    A Sureda, P Bader, S Cesaro, P Dreger, R F Duarte, C Dufour in Bone Marrow Transplantation (2015)

  15. Article

    Open Access

    Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

    A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogenei...

    J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro in Bone Marrow Transplantation (2015)

  16. No Access

    Article

    Natural history of acute lymphoblastic leukemia in neurofibromatosis type 1 monozygotic twins

    M Galbiati, A Lettieri, C Micalizzi, S Songia, C Morerio, A Biondi, C Dufour in Leukemia (2013)

  17. No Access

    Article

    Front-line immunosuppressive treatment of acquired aplastic anemia

    In this article, front-line immunosuppressive therapy (IST) for acquired plastic anemia (AA) is illustrated and discussed. Also second-line and salvage options are briefly illustrated. First-line IST should co...

    C Dufour, J Svahn, A Bacigalupo in Bone Marrow Transplantation (2013)

  18. No Access

    Article

    Diagnosis of acquired aplastic anemia

    Since the introduction of the concept of aplastic anemia (AA) by Paul Ehrlich in 1888 and despite the current better understanding of the underlying mechanisms involved in this disease, a clear delimitation am...

    A Rovó, A Tichelli, C Dufour in Bone Marrow Transplantation (2013)

  19. No Access

    Chapter and Conference Paper

    Intérêt d’une structure médico-infirmière pour le suivi des patientes sous chimiothérapie orale (cancer du sein métastatique)

    Les thérapies orales sont en plein développement dans la prise en charge des tumeurs solides. Elles ne sont pas dénuées de toxicités et leur suivi à domicile demande une gestion extrêmement rigoureuse [1, 2].

    M. Vincent, L. Venat-Bouvet, O. Gasnier in Acquis et limites en sénologie / Assets an… (2013)

  20. No Access

    Article

    Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model

    B-acute lymphoblastic leukemia (B-ALL) represents the most common pediatric hematological tumor that derives from the aberrant proliferation of early B lymphocytes in the bone marrow. Although most of the B-AL...

    S Canale, C Cocco, C Frasson, E Seganfreddo, E Di Carlo, E Ognio, C Sorrentino in Leukemia (2011)

previous disabled Page of 2